Using FOIA to Read Scientists’ Emails

Journalists and activists use the Freedom of Information Act to expose academics’ relationships with industry.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

PIXABAY, SONELLast year, it was Michael Mann and “Climategate.” Now it’s Kevin Folta and genetically modified organisms (GMOs). In both cases, journalists or activists are using federal law to peek at professors’ emails, stirring the debate about transparency in academia.

The latest saga began earlier this year when a nonprofit organization called US Right to Know requested—and received—Folta’s correspondence with agricultural giant Monsanto through the Freedom of Information Act (FOIA), which allows for public release of documents from federal agencies. Folta studies fruit crop genomics, and the emails revealed that Monsanto had provided funds for Folta’s public communication outreach project.

“This is a great 3rd-party approach to developing the advocacy that we’re looking to develop,” Michael Lohuis, the director of crop biometrics at Monsanto, wrote in a 2014 email to Folta, The New York Times—which also requested the correspondence—reported last week.

Folta told the New York Times that “nobody tells me what to say,” but that he understood why others could perceive the hand of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies